[1] ANWANWAN D, SINGH SK, SINGH S, et al. Challenges in liver cancer and possible treatment approaches[J].Biochim Biophys Acta Rev Cancer,2020,1873(1):314-317.
[2] 陈勇. CT引导下经皮微波消融与常规化疗栓塞治疗肝癌生存情况的随访观察[J].肝脏, 2019, 24(1):68-72.
[3] 谢万桃, 彭慈军, 李雄雄,等. 肝细胞癌患者Th17细胞及细胞因子IL-17、IL-6变化的临床意义[J].中华肝胆外科杂志, 2019, 25(7):526-530.
[4] BERKHOUT L, BARIKBIN R, SCHILLER B, et al. Deletion of tumour necrosis factor alpha receptor 1 elicits an increased TH17 immune response in the chronically inflamed liver[J].Sci Rep,2019,9(1):4232.
[5] 李进. 肝病诊疗指南[M]. 北京:军事医学科学出版社, 2012:33-35.
[6] 苏少慧, 樊梅月, 陈伟华, 等. 临床实用肝脏病学[M]. 石家庄:河北科学技术出版社, 2011:35-38.
[7] PERRODIN S, LACHENMAYER A, MAURER M, et al. Percutaneous stereotactic image-guided microwave ablation for malignant liver lesions[J].Sci Rep,2019,9(1):36-39.
[8] 刘会永, 万象新, 符孔, 等. CT引导下经皮微波消融术与腹腔镜手术治疗原发性肝癌的疗效比较[J].介入放射学杂志, 2019, 28(10):991-995.
[9] ALBHAISI SAM, BAJAJ JS, SANYAL AJ. Role of gut microbiota in liver disease[J].Am J Physiol Gastrointest Liver Physiol,2020, 318(1):G84-G98.
[10] 尹彩星, 司海超, 范兆阳, 等. 右美托咪定对肝癌根治术患者Th1、Th2、Th17、Treg细胞及相关细胞因子的影响[J].广东医学, 2019, 40(24):98-102.
[11] SALAZAR Y, ZHENG X, BRUNN D, et al. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer[J].J Clin Invest,2020,130(7):3560-3575.
[12] YAN C, RICHMOND A. Th9 and Th17 cells: the controversial twins in cancer immunity[J].J Clin Invest,2020,130(7):3409-3411.
[13] YANG Y M, KIM S Y, SEKI E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets[J].Semin Liver Dis,2019,39(1):26-42.
2022, Vol. 39 
